Explore

Trendline Trendline
Eli Lilly's Retatrutide Shows Promising Results in Obesity Trial with Significant Weight Loss

Eli Lilly's Retatrutide Shows Promising Results in Obesity Trial with Significant Weight Loss

Eli Lilly's Retatrutide Shows Promising Results in Obesity Trial with Significant Weight Loss
Trendline Trendline
Arsenal Medical Receives FDA Approval for NeoCast Trial in Chronic Subdural Hematoma

Arsenal Medical Receives FDA Approval for NeoCast Trial in Chronic Subdural Hematoma

Arsenal Medical Receives FDA Approval for NeoCast Trial in Chronic Subdural Hematoma
Trendline Trendline
Parabilis Files for IPO Following $2.3 Billion Collaboration with Regeneron

Parabilis Files for IPO Following $2.3 Billion Collaboration with Regeneron

Parabilis Files for IPO Following $2.3 Billion Collaboration with Regeneron
Trendline Trendline
Bayer Seeks FDA Approval for Kerendia in Type 1 Diabetes

Bayer Seeks FDA Approval for Kerendia in Type 1 Diabetes

Bayer Seeks FDA Approval for Kerendia in Type 1 Diabetes
Trendline Trendline
Infex Therapeutics Advances in Bronchiectasis Treatment with Promising Trial Results

Infex Therapeutics Advances in Bronchiectasis Treatment with Promising Trial Results

Infex Therapeutics Advances in Bronchiectasis Treatment with Promising Trial Results
Trendline Trendline
Eli Lilly's Retatrutide Shows Promising Results in Obesity Treatment Trial

Eli Lilly's Retatrutide Shows Promising Results in Obesity Treatment Trial

Eli Lilly's Retatrutide Shows Promising Results in Obesity Treatment Trial
Trendline Trendline
Pfizer Advances Pediatric Pneumococcal Vaccine Program with Promising Phase 2 Results

Pfizer Advances Pediatric Pneumococcal Vaccine Program with Promising Phase 2 Results

Pfizer Advances Pediatric Pneumococcal Vaccine Program with Promising Phase 2 Results
Trendline Trendline
Qihan Biotech Receives FDA Clearance for Innovative CAR-T Therapy for Autoimmune Diseases

Qihan Biotech Receives FDA Clearance for Innovative CAR-T Therapy for Autoimmune Diseases

Qihan Biotech Receives FDA Clearance for Innovative CAR-T Therapy for Autoimmune Diseases
Trendline Trendline
Pfizer Advances 25-Valent Pneumococcal Vaccine to Phase 3 Trials for Enhanced Protection

Pfizer Advances 25-Valent Pneumococcal Vaccine to Phase 3 Trials for Enhanced Protection

Pfizer Advances 25-Valent Pneumococcal Vaccine to Phase 3 Trials for Enhanced Protection
Trendline Trendline
Bayer Seeks FDA Approval for Kerendia in Type 1 Diabetes, Aiming to Expand Treatment Options

Bayer Seeks FDA Approval for Kerendia in Type 1 Diabetes, Aiming to Expand Treatment Options

Bayer Seeks FDA Approval for Kerendia in Type 1 Diabetes, Aiming to Expand Treatment Options
Trendline Trendline
Neurosoft Bioelectronics Secures $7.5M to Advance Brain-Computer Interface Technology

Neurosoft Bioelectronics Secures $7.5M to Advance Brain-Computer Interface Technology

Neurosoft Bioelectronics Secures $7.5M to Advance Brain-Computer Interface Technology
Trendline Trendline
UCB's Marie Teil Leads Initiative to Enhance Healthcare for Women of Childbearing Age

UCB's Marie Teil Leads Initiative to Enhance Healthcare for Women of Childbearing Age

UCB's Marie Teil Leads Initiative to Enhance Healthcare for Women of Childbearing Age